JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2022-07-16 ms1000001586655204

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：神经药理
经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见

48 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2022-05-12 ms7000002017209868

审稿速度:1.0 | 投稿命中率:25.0
经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

SCI期刊是如何分区的？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

选刊时需结合IF进行吗？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2020-02-22 14841a7em34暂无昵称

您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表:
你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？

130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？

148 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2019-06-22 qxl路漫漫

需要原始数据吗130****3681 2019-05-23 发表::
这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表:
这个杂志怎么样啊

130****3681 2019-05-23 发表:: 这个杂志怎么样啊

166 0

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2019-05-23 1301f90d5dm

这个杂志怎么样啊183****6078 2018-11-08 发表::
研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表:
投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高

183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高

184 0

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2018-11-28 12117f6cm43暂无昵称

你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表:
这个收版面费吗

152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗

160 0

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2018-11-08 1831f13977m

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高

203 0

[GetPortalCommentsPageByObjectIdResponse(id=1232745, encodeId=aa551232e4505, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：神经药理 经验分享：总体来说非常失望，在需要支付审稿费的情况下审了三个多月，最后给出直接拒稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8405708427, createdName=ms1000001586655204, createdTime=Sat Jul 16 08:43:50 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219118, encodeId=d5aa1219118bd, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要审稿费，审稿很快，但是给拒了，推荐了另一家杂志，然后另一家杂志秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cb65516461, createdName=ms7000002017209868, createdTime=Thu May 12 16:19:10 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093926, encodeId=da4b10939261f, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093925, encodeId=fbba1093925e3, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585176, encodeId=41165851e669, content=您好，请问您这个问题解决了吗，我现在也遇到了这个问题，应该怎么付费呢130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, beContent=130****9643暂无昵称 2018-11-28 00:00:00 发表: 你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05305280802, createdName=14841a7em34暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572782, encodeId=4de15e27824d, content=需要原始数据吗130****3681 2019-05-23 发表:: 这个杂志怎么样啊130****3681 2019-05-23 00:00:00 发表: 这个杂志怎么样啊, beContent=130****3681 2019-05-23 发表:: 这个杂志怎么样啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1f51731528, createdName=qxl路漫漫, createdTime=Sat Jun 22 00:00:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571402, encodeId=69d05e1402c6, content=这个杂志怎么样啊183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高183****6078 2018-11-08 15:10:00 发表: 投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=183****6078 2018-11-08 发表:: 研究方向：离子通道;瘙痒; 接收率：约50% 审稿时间：约1个月投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d5f2113038, createdName=1301f90d5dm, createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563729, encodeId=a4ca563e29c9, content=你好，我想问一下投J PHARMACOL EXP THER杂志的时候，怎样付过去审稿费的啊？152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, beContent=152****6931 2017-11-22 08:21:00 发表: 这个收版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622227664, createdName=12117f6cm43暂无昵称, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562940, encodeId=59c2562940cd, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，靶点清楚，机制涉及不是很深，审稿人评论实验设计合理，小修，从投稿到接收共29天，效率非常高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc142076435, createdName=1831f13977m, createdTime=Thu Nov 08 15:10:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549389, encodeId=02d8549389f7, content=这个收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ee12073236, createdName=1521f0930bm, createdTime=Wed Nov 22 08:21:00 CST 2017, time=2017-11-22, status=1, ipAttribution=)]

2017-11-22 1521f0930bm

这个收版面费吗

341 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务